Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology

Brain Pathology

Volumn 26, Issue 3, 2016, Pages 371-386

  Stratmann, Katharina ^a   Heinsen, Helmut ^a   Korf, Horst Werner ^a   Del Turco, Domenico ^b   Ghebremedhin, Estifanos ^b   Seidel, Kay ^a   Bouzrou, Mohamed ^a   Grinberg, Lea T ^c,d   Bohl, Jürgen ^e   Wharton, Stephen B ^f   Den Dunnen, Wilfred ^g   Rüb, Udo ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^f UNIVERSITY OF SHEFFIELD   (United Kingdom)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

allocortex; Alzheimer's disease; cytoskeletal pathology; entorhinal region; prion like diseases; subcortical nuclei; tau protein

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; BASAL FOREBRAIN; BASAL GANGLION; CLAUSTRUM; CONTROLLED STUDY; EFFERENT NERVE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOLECULAR PATHOLOGY; NERVE PROJECTION; SUBSTANTIA NIGRA; TEMPORAL LOBE; TISSUE SECTION; VENTRAL TEGMENTUM; BRAIN; CYTOSKELETON; DISEASE EXACERBATION; MIDDLE AGED; PATHOLOGY;

AGED; ALZHEIMER DISEASE; BRAIN; CYTOSKELETON; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; TAU PROTEINS;

EID: 84940200391     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12289     Document Type: Article

References (98)

1. Aggleton JP, Burton MJ, Passingham RE, (1980) Cortical and subcortical afferents to the amygdala of the rhesus monkey (Macaca mulatta). Brain Res 190: 347-368.
2. Airaksinen MS, Paetau A, Paljarvi L, Reinikainen K, Riekkinen P, Suomalainen R, Punula P, (1991) Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience 44: 465-481.
3. Airaksinen MS, Reinikainen K, Riekkinen P, Panula P, (1991) Neurofibrillary tangles and histamine-containing neurons in Alzheimer hypothalamus. Agents Actions 33: 104-107.
4. Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, et al (2008) Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol 18: 484-496.
5. Alonso AC, Li B, Grundke-Iqbal I, Iqbal K, (2008) Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies. Curr Alzheimer Res 5: 375-384.
6. Alzheimer A, (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiat Psych Gerichtl Med 64: 146-148.
7. Amaral DG, Cowan WM, (1980) Subcortical afferents to the hippocampal formation in the monkey. J Comp Neurol 189: 573-591.
8. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E, (2011) Alzheimer's disease. Lancet 377: 1019-1031.
9. Bancher C, Braak H, Fischer P, Jellinger KA, (1993) Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci Lett 162: 179-182.
10. Bancher C, Jellinger K, Lassmann H, Fischer P, Leblhuber F, (1996) Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia. Eur Arch Psychiatry Clin Neurosci 246: 137-146.
11. Blennow K, de Leon MJ, Zetterberg H, (2006) Alzheimer's disease. Lancet 368: 387-403.
12. Braak E, Braak H, Mandelkow EM, (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87: 554-567.
13. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K, (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112: 389-404.
14. Braak H, Braak E, (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259.
15. Braak H, Braak E, (1991) Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol 81: 261-268.
16. Braak H, Braak E, (1992) The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15: 6-31.
17. Braak H, Braak E, Yilmazer D, Bohl J, (1996) Functional anatomy of human hippocampal formation and related structures. J Child Neurol 11: 265-275.
18. Braak H, Del Trecidi K, (2015) Neuroanatomy and pathology of sporadic Alzheimer's disease. Adv Anat Embryol Cell Biol 215: 1-162.
19. Braak H, Del Tredici K, (2009) Neuroanatomy and pathology of sporadic Parkinson's disease. Adv Anat Embryol Cell Biol 201: 1-119.
20. Braak H, Rüb U, Del Tredici K, (2003) Involvement of precerebellar nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 29: 60-76.
21. Braak H, Thal DR, Ghebremedhin E, Del Tredici K, (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70: 960-969.
22. Brunden KR, Ballatore C, Crowe A, Smith AB III, Lee VM, Trojanowski JQ, (2010) Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors. Exp Neurol 223: 304-310.
23. Brunden KR, Trojanowski JQ, Lee VM, (2009) Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat Rev Drug Discov 8: 783-793.
24. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
25. De Lacoste MC, White CL III, (1993) The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol Aging 14: 1-16.
26. De Vos KJ, Grierson AJ, Ackerley S, Miller CC, (2008) Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 31: 151-173.
27. Dickson DW, (1997) Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies. Neurobiol Aging 18: S21-S26.
28. Duyckaerts C, Braak H, Brion JP, Buée L, Del Tredici K, Goedert M, et al (2015) PART is part of Alzheimer disease. Acta Neuropathol 129: 749-756.
29. Duyckaerts C, Delatour B, Potier MC, (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118: 5-36.
30. Duyckaerts C, Hauw JJ, (1997) Diagnosis and staging of Alzheimer disease. Neurobiol Aging 18: S33-S42.
31. Duyckaerts C, Hauw JJ, (1997) Prevalence, incidence and duration of Braak's stages in the general population: can we know? Neurobiol Aging 18: 362-369.
32. Ferrer I, (2012) Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia. Prog Neurobiol 97: 38-51.
33. German DC, White CL III, Sparkman DR, (1987) Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience 21: 305-312.
34. Ghebremedhin E, Schultz C, Thal DR, Rüb U, Ohm TG, Braak E, Braak H, (2001) Gender and age modify the association between APOE and AD-related neuropathology. Neurology 56: 1696-1701.
35. Goedert M, (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 16: 460-465.
36. Goedert M, Clavaguera F, Tolnay M, (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33: 317-325.
37. Goedert M, Klug A, Crowther RA, (2006) Tau protein, the paired helical filament and Alzheimer's disease. J Alzheimers Dis 9: 195-207.
38. Gong CX, Grundke-Iqbal I, Iqbal K, (2010) Targeting tau protein in Alzheimer's disease. Drugs Aging 27: 351-365.
39. Grinberg LT, Rüb U, Ferretti RE, Nitrini R, Farfel JM, Polichiso L, et al (2009) The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? Neuropathol Appl Neurobiol 35: 406-416.
40. Grudzien A, Shaw P, Weintraub S, Bigio E, Mash DC, Mesulam MM, (2007) Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 28: 327-335.
41. Hornung JP, (2003) The human raphe nuclei and the serotonergic system. J Chem Neuroanat 26: 331-343.
42. Hsu DT, Price JL, (2009) Paraventricular thalamic nucleus: subcortical connections and innervation by serotonin, orexin, and corticotropin-releasing hormone in macaque monkeys. J Comp Neurol 512: 825-848.
43. Hyman BT, (1997) The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies. Neurobiol Aging 18: S27-S32.
44. Hyman BT, Trojanowski JQ, (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56: 1095-1097.
45. Insausti R, Amaral DG, Cowan WM, (1987) The entorhinal cortex of the monkey: III. Subcortical afferents. J Comp Neurol 264: 396-408.
46. Iqbal K, Grundke-Iqbal I, (2008) Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. J Cell Mol Med 12: 38-55.
47. Iqbal K, Grundke-Iqbal I, (2011) Opportunities and challenges in developing Alzheimer disease therapeutics. Acta Neuropathol 122: 543-549.
48. Iqbal K, Liu F, Gong CX, Alonso AC, Grundke-Iqbal I, (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118: 53-69.
49. Iqbal K, Liu F, Gong CX, Grundke-Iqbal I, (2010) Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 7: 656-664.
50. Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ, (2004) Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging 25: 619-627.
51. Jalbert JJ, Daiello LA, Lapane KL, (2008) Dementia of the Alzheimer type. Epidemiol Rev 30: 15-34.
52. Jellinger KA, (2006) Alzheimer 100-highlights in the history of Alzheimer research. J Neural Transm 113: 1603-1623.
53. Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, et al (2015) PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol 129: 757-762.
54. Jones EG, Burton H, Saper CB, Swanson LW, (1976) Midbrain, diencephalic and cortical relationships of the basal nucleus of Meynert and associated structures in primates. J Comp Neurol 167: 385-419.
55. Jucker M, Walker LC, (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70: 532-540.
56. Kromer Vogt LJ, Hyman BT, Van Hoesen GW, Damasio AR, (1990) Pathological alterations in the amygdala in Alzheimer's disease. Neuroscience 37: 377-385.
57. Kuljis RO, (1994) Lesions in the pulvinar in patients with Alzheimer's disease. J Neuropathol Exp Neurol 53: 202-211.
58. Lace G, Savva GM, Forster G, de Silva R, Brayne C, Matthews FE, et al (2009) Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. Brain 132: 1324-1334.
59. Lace GL, Wharton SB, Ince PG, (2007) A brief history of tau: the evolving view of the microtubule-associated protein tau in neurodegenerative diseases. Clin Neuropathol 26: 43-58.
60. Lavoie B, Parent A, (1991) Serotoninergic innervation of the thalamus in the primate: an immunohistochemical study. J Comp Neurol 312: 1-18.
61. Lei S, (2012) Serotonergic modulation of neural activities in the entorhinal cortex. Int J Physiol Pathophysiol Pharmacol 4: 201-210.
62. Mandelkow E, Song YH, Schweers O, Marx A, Mandelkow EM, (1995) On the structure of microtubules, tau, and paired helical filaments. Neurobiol Aging 16: 347-354.
63. Mantyh PW, (1983) Connections of midbrain periaqueductal gray in the monkey. I. Ascending efferent projections. J Neurophysiol 49: 567-581.
64. Mantyh PW, (1983) Connections of midbrain periaqueductal gray in the monkey. II. Descending efferent projections. J Neurophysiol 49: 582-594.
65. Markesbery WR, (1997) Neuropathological criteria for the diagnosis of Alzheimer's disease. Neurobiol Aging 18: S13-S19.
66. Mehler WR, (1980) Subcortical afferent connections of the amygdala in the monkey. J Comp Neurol 190: 733-762.
67. Mesulam M, Shaw P, Mash D, Weintraub S, (2004) Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55: 815-828.
68. Mesulam MM, (1999) Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 24: 521-529.
69. Michelsen KA, Schmitz C, Steinbusch HW, (2007) The dorsal raphe nucleus-from silver stainings to a role in depression. Brain Res Rev 55: 329-342.
70. Norrby E, (2011) Prions and protein-folding diseases. J Intern Med 270: 1-14.
71. Novak P, Prcina M, Kontsekova E, (2011) Tauons and prions: infamous cousins? J Alzheimers Dis 26: 413-430.
72. Parvizi J, Van Hoesen GW, Damasio A, (1998) Severe pathological changes of parabrachial nucleus in Alzheimer's disease. Neuroreport 9: 4151-4154.
73. Parvizi J, Van Hoesen GW, Damasio A, (2001) The selective vulnerability of brainstem nuclei to Alzheimer's disease. Ann Neurol 49: 53-66.
74. Pei JJ, Sjogren M, Winblad B, (2008) Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets. Curr Opin Psychiatry 21: 555-561.
75. Pritchard TC, Hamilton RB, Norgren R, (2000) Projections of the parabrachial nucleus in the old world monkey. Exp Neurol 165: 101-117.
76. Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P, (2012) Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 11: 618-628.
77. Raji CA, Becker JT, Tsopelas ND, Price JC, Mathis CA, Saxton JA, et al (2008) Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B. J Neurosci Methods 172: 277-282.
78. Rebeck GW, Hyman BT, (1993) Neuroanatomical connections and specific regional vulnerability in Alzheimer's disease. Neurobiol Aging 14: 45-47.
79. Reiniger L, Lukic A, Linehan J, Rudge P, Collinge J, Mead S, Brandner S, (2011) Tau, prions and abeta: the triad of neurodegeneration. Acta Neuropathol 121: 5-20.
80. Rodriguez JJ, Noristani HN, Verkhratsky A, (2012) The serotonergic system in ageing and Alzheimer's disease. Prog Neurobiol 99: 15-41.
81. Russchen FT, Amaral DG, Price JL, (1985) The afferent connections of the substantia innominata in the monkey, Macaca fascicularis. J Comp Neurol 242: 1-27.
82. Rüb U, Del Tredici K, Del Turco D, Braak H, (2002) The intralaminar nuclei assigned to the medial pain system and other components of this system are early and progressively affected by the Alzheimer's disease-related cytoskeletal pathology. J Chem Neuroanat 23: 279-290.
83. Rüb U, Del Tredici K, Schultz C, Thal DR, Braak E, Braak H, (2000) The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei. Neuropathol Appl Neurobiol 26: 553-567.
84. Rüb U, Del Tredici K, Schultz C, Thal DR, Braak E, Braak H, (2001) The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology. Acta Neuropathol 101: 555-564.
85. Sadikot AF, Parent A, Smith Y, Bolam JP, (1992) Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a light and electron microscopic study of the thalamostriatal projection in relation to striatal heterogeneity. J Comp Neurol 320: 228-242.
86. Saper CB, German DC, (1987) Hypothalamic pathology in Alzheimer's disease. Neurosci Lett 74: 364-370.
87. Saper CB, Wainer BH, German DC, (1987) Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer's disease. Neuroscience 23: 389-398.
88. Sassin I, Schultz C, Thal DR, Rüb U, Arai K, Braak E, Braak H, (2000) Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol 100: 259-269.
89. Simic G, Stanic G, Mladinov M, Jovanov-Milosevic N, Kostovic I, Hof PR, (2009) Does Alzheimer's disease begin in the brainstem? Neuropathol Appl Neurobiol 35: 532-554.
90. Smithson KG, MacVicar BA, Hatton GI, (1983) Polyethylene glycol embedding: a technique compatible with immunocytochemistry, enzyme histochemistry, histofluorescence and intracellular staining. J Neurosci Methods 7: 27-41.
91. Stokin GB, Goldstein LS, (2006) Axonal transport and Alzheimer's disease. Annu Rev Biochem 75: 607-627.
92. Terwel D, Dewachter I, Van LF, (2002) Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease. Neuromolecular Med 2: 151-165.
93. Thal DR, Rüb U, Orantes M, Braak H, (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58: 1791-1800.
94. Veazey RB, Amaral DG, Cowan WM, (1982) The morphology and connections of the posterior hypothalamus in the cynomolgus monkey (Macaca fascicularis). II. Efferent connections. J Comp Neurol 207: 135-156.
95. Wadsworth JD, Collinge J, (2011) Molecular pathology of human prion disease. Acta Neuropathol 121: 69-77.
96. Walker LC, Diamond MI, Duff KE, Hyman BT, (2013) Mechanisms of Protein Seeding in Neurodegenerative Diseases. Arch Neurol 70: 304-310.
97. Wilson AC, Dugger BN, Dickson DW, Wang DS, (2011) TDP-43 in aging and Alzheimer's disease-a review. J Clin Exp Pathol 4: 147-155.
98. Zrinzo L, Zrinzo LV, (2008) Surgical anatomy of the pedunculopontine and peripeduncular nuclei. Br J Neurosurg 22 (Suppl. 1): S19-S24.